WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner-Reference-Cited by-同舟云学术

WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner

Published:2016-09-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lal Shruti,Zarei Mahsa,Chand Saswati N.,Dylgjeri Emanuela,Mambelli-Lisboa Nicole C.,Pishvaian Michael J.,Yeo Charles J.,Winter Jordan M.,Brody Jonathan R.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep33323.pdf

Reference52 articles.

1. Jemal, A. et al. Cancer statistics, 2007. CA Cancer J Clin 57, 43–66 (2007).

2. Jones, S. et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321, 1801–1806 (2008).

3. Rozenblum, E. et al. Tumor-suppressive Pathways in Pancreatic Carcinoma. Cancer Research 57, 1731–1734 (1997).

4. Oza, A. M. et al. Olaparib combined with chemotherapy for recurrent platinum-sensitive ovarian cancer: a randomised phase 2 trial. The Lancet Oncology 16, 87–97 (2015).

5. Lowery, M. A. & O’Reilly, E. M. Novel Therapeutics for Pancreatic Adenocarcinoma. Hematology/Oncology Clinics of North America 29, 777–787 (2015).

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adavosertib and beyond: Biomarkers, drug combination and toxicity of WEE1 inhibitors;Critical Reviews in Oncology/Hematology;2024-01

2. Therapeutic poly(amino acid)s as drug carriers for cancer therapy;Chinese Chemical Letters;2023-06

3. Treatment for ovarian clear cell carcinoma with combined inhibition of WEE1 and ATR;Journal of Ovarian Research;2023-04-22

4. Genomic Profiling of Lower-Grade Gliomas Subtype with Distinct Molecular and Clinicopathologic Characteristics via Altered DNA-Damage Repair Features;Journal of Molecular Neuroscience;2023-04-17

5. Genomic Profiling of lower-grade gliomas subtype with distinct molecular and clinicopathologic characteristics via altered DNA-damage repair features;2023-02-16